Disease-modifying effects of ranibizumab for central retinal vein occlusion. Huang JM, Khurana RN, Ghanekar A, Wang PW, et al. Graefes Arch Clin Exp Ophthalmol 2021 Oct 6. pii: 10.1007/s00417-021-05224.

Read + Share

Amedeo Smart

Independent Medical Education

Huang JM, Khurana RN, Ghanekar A, Wang PW, et al. Disease-modifying effects of ranibizumab for central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2021 Oct 6. pii: 10.1007/s00417-021-05224.
PMID: 34613454